74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Solventum Corp
Open
71.4 -6.41
Overview
Share price change
24h
Min
71.33
Max
76.66
Income | -91M 31M |
|---|---|
Sales | -8M 2.1B |
P/E Sector Avg | 27.551 38.186 |
EPS | 1.41 |
Profit margin | 1.495 |
Employees | 22,000 |
EBITDA | -137M 270M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +8.5% upside |
Next Earnings | 8 May 2025 |
|---|
Market Cap | 361M 13B |
|---|---|
Previous open | 77.81 |
Previous close | 71.4 |
Solventum Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Solventum Corp Forecast
Price Target
By TipRanks
8.5% upside
12 Months Forecast
Average 82.83 USD 8.5%
High 88 USD
Low 75 USD
Based on 7 Wall Street analysts offering 12 month price targets forSolventum Corp - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Solventum Corp
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
